科学文献 - 传奇生物

科学文献

我们与学术机构开展合作研究，以评估我们的管线产品。以下是发表的相关文献。

年：

Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to PI, IMiD and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice

MV Mateos, K Weisel, T Martin, JG. Berdeja, A Jakubowia […]

Five‑year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR‑B38M chimeric antigen receptor T cells in the LEGEND‑2 study: a case report

BY Wang, WH Zhao, YX Chen, XM Cao, Y Yang, YL Zhang, FX […]

Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice

Delforge M, Vekemans M, Depaus J, Meuleman N, Van De Ve […]

Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma

Tom Martin, Saad Z. Usmani, Jordan M. Schecter, Tito Ro […]

Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study

Adam D. Cohen, Parameswaran Hari, Myo Htut, Jesus G. Be […]

本网站使用Cookies来改善您的整体体验，让您下次访问网站时更加轻松快捷，为您带来更好的服务。具体内容请参阅隐私政策 Cookie政策。